The Catalogue
Research peptides
Reference compounds organised by health goal. Select any compound to view its profile, mechanism and dosing reference.
Retatrutide
Next-generation metabolic compound targeting weight loss through three simultaneous receptor pathways.
Mechanism of Action
Activates GLP-1, GIP, and glucagon receptors simultaneously, suppressing appetite, enhancing insulin secretion, and boosting energy expenditure in concert.
Key Benefits
Significant body weight reduction (up to ~24% in Phase 2 trials), improved glycemic control, favorable lipid profile changes, and superior fat-loss results compared to dual agonists.
Dosage Reference
- Starting dose1 mg/week
- Maintenance dose4–12 mg/week
- TitrationEvery 4 weeks
- Cycle length12–48 weeks
Tesamorelin
A clinically validated growth hormone-releasing peptide proven to reduce visceral fat.
Mechanism of Action
Stimulates the pituitary gland to release endogenous growth hormone in a pulsatile, physiological pattern, specifically targeting visceral adipose tissue metabolism without disrupting blood glucose.
Key Benefits
Clinically proven reduction of visceral and abdominal fat, improved lipid profiles, mild IGF-1 elevation, and emerging evidence for cognitive and neuroprotective benefits.
Dosage Reference
- Standard dose2 mg/day
- TimingBefore bed
- Cycle length6–12 months
- RouteSubcutaneous
MOTS-c
A frontier longevity peptide encoded in the mitochondrial genome, regulating metabolism at the cellular level.
Mechanism of Action
Activates the AMPK pathway to regulate glucose and lipid metabolism. Translocates to the nucleus under metabolic stress to directly influence gene expression. Levels naturally decline with age.
Key Benefits
Improved insulin sensitivity, enhanced exercise endurance, anti-obesity metabolic signaling, and longevity benefits at the cellular and mitochondrial level.
Dosage Reference
- Typical dose5–10 mg
- Frequency3–5x per week
- TimingPre-workout / AM
- RouteSubcutaneous
5-Amino-1MQ
A novel small molecule that reprograms fat cell metabolism by targeting a key enzyme in adipose tissue.
Mechanism of Action
Inhibits Nicotinamide N-Methyltransferase (NNMT), raising SAM levels and increasing NAD+ precursor availability, directly shifting fat cell metabolism away from lipid storage.
Key Benefits
Targeted fat loss, particularly in adipose tissue. Potential for metabolic reprogramming, improved energy utilization, and muscle preservation during caloric deficits.
Dosage Reference
- Typical dose50–100 mg
- Frequency1–2x daily
- TimingWith/without food
- Cycle length8–12 weeks
AOD-9604
Isolates the fat-burning mechanism of growth hormone, without the insulin or growth side effects.
Mechanism of Action
Mimics the lipolytic C-terminal fragment of human growth hormone, stimulating fat breakdown and inhibiting new fat formation, without activating IGF-1 pathways or affecting blood glucose levels.
Key Benefits
Targeted fat loss, particularly visceral fat, with an exceptionally clean safety profile. Additional research into cartilage repair and osteoarthritis applications.
Dosage Reference
- Injectable dose250–300 mcg
- Oral dose500–1000 mcg
- TimingMorning, fasted
- Cycle length8–12 weeks
BPC-157
Potent localized tissue repair peptide derived from a naturally occurring protein in gastric juice.
Mechanism of Action
Promotes angiogenesis, upregulates growth hormone receptors at injury sites, modulates nitric oxide synthesis, and activates the FAK-paxillin pathway to accelerate tissue repair.
Key Benefits
Accelerated healing of tendons, ligaments, and muscle tissue. Gastroprotective, anti-inflammatory, and neuroprotective. Particularly effective for gut lining repair.
Dosage Reference
- Typical dose250–500 mcg
- Oral dose500–1000 mcg
- Injection siteNear injury / SubQ
- Cycle length4–6 weeks
TB-500
Systemic healing peptide that mobilizes the body's own repair cells throughout tissue and muscle.
Mechanism of Action
Regulates actin, the protein responsible for cell structure and movement. Promotes cell migration to injury sites, reduces pro-inflammatory cytokines, and supports cardiac and connective tissue repair.
Key Benefits
System-wide healing response, improved flexibility and range of motion, reduced inflammation, and accelerated recovery from musculoskeletal injuries.
Dosage Reference
- Loading dose2–2.5 mg, 2x/wk
- Maintenance2–2.5 mg, 2x/mo
- Loading phase4–6 weeks
- RouteSubQ or IM
Wolverine Blend
The most comprehensive healing stack, combining targeted and systemic tissue repair in a single protocol.
Mechanism of Action
BPC-157 drives localized, receptor-mediated tissue repair while TB-500 provides systemic cell mobilization and anti-inflammatory support, together covering both targeted and whole-body recovery.
Key Benefits
Enhanced overall recovery from acute and chronic injuries, reduced healing time, improved connective tissue integrity, and combined gut and musculoskeletal support.
Dosage Reference
- Dose1 mg/day
- Schedule5 on / 2 off
- Cycle length4–8 weeks
- RouteSubcutaneous
KPV
A potent anti-inflammatory tripeptide with direct activity in gut tissue, stable for oral delivery.
Mechanism of Action
Activates MC1R and MC3R receptors while directly inhibiting the NF-κB inflammatory pathway, reducing IL-1β, TNF-α, and IL-6 both systemically and locally in gut mucosa.
Key Benefits
Targeted reduction of gut inflammation (IBD, Crohn's, colitis), accelerated wound healing, and systemic anti-inflammatory activity. Orally stable and gut-active.
Dosage Reference
- Oral dose500 mcg – 2 mg
- Injectable dose100–500 mcg
- TimingEmpty stomach
- Cycle length4–8 weeks
GHK-Cu
A naturally occurring copper peptide that resets gene expression toward a youthful regenerative state.
Mechanism of Action
Activates over 4,000 genes related to tissue remodeling, collagen and elastin synthesis, antioxidant defense, stem cell activation, and anti-inflammatory signaling, effectively resetting cellular behavior.
Key Benefits
Skin rejuvenation and collagen production, wound and tissue healing, hair follicle stimulation, anti-inflammatory effects, and broad neuroprotective and anti-aging activity.
Dosage Reference
- Injectable dose1–2 mg
- Frequency2–3x per week
- Cycle length12–24 months
CJC-1295 + Ipamorelin
The gold-standard GH optimization stack, dual-signal stimulation that mirrors the body's natural release pattern.
Mechanism of Action
CJC-1295 (no DAC) stimulates the pituitary via GHRH receptors; Ipamorelin triggers GH release via ghrelin mimicry, together producing a strong, clean GH pulse without raising cortisol or prolactin.
Key Benefits
Increased lean muscle mass, accelerated fat loss, improved recovery speed, enhanced deep sleep quality, and anti-aging effects via natural IGF-1 elevation.
Dosage Reference
- CJC-1295 dose100–300 mcg
- Ipamorelin dose100–300 mcg
- TimingBefore bed
- Cycle length8–12 wk on / 4 off
NAD+
The master molecule of cellular energy, essential for mitochondrial function, DNA repair, and longevity signaling.
Mechanism of Action
Serves as a critical cofactor in mitochondrial energy production and redox reactions. Activates sirtuins (SIRT1–SIRT7), key longevity enzymes, and drives DNA repair via PARP activation.
Key Benefits
Enhanced cellular energy, improved cognitive function, DNA repair support, anti-aging signaling through sirtuin activation, and broad metabolic improvement.
Dosage Reference
- SubQ dose50–100 mg/day
- RouteSubcutaneous
- TimingMorning
- Cycle lengthOngoing
SS-31
The most targeted mitochondrial repair compound available, directly stabilizing the electron transport chain.
Mechanism of Action
Selectively concentrates in the inner mitochondrial membrane, binds cardiolipin, and stabilizes electron transport chain complexes, reducing mitochondrial ROS and restoring efficient ATP production.
Key Benefits
Improved mitochondrial function, reduced oxidative stress, cardiac and renal tissue protection, enhanced exercise capacity, and reversal of age-related mitochondrial decline.
Dosage Reference
- Typical dose1–5 mg
- FrequencyDaily or 5x/week
- TimingMorning
- RouteSubcutaneous
Epithalon
The only compound with direct evidence of telomere elongation, a cornerstone of longevity medicine.
Mechanism of Action
Stimulates the pineal gland to produce melatonin and activates telomerase, the enzyme responsible for maintaining and elongating telomeres, slowing chromosomal aging at the most fundamental level.
Key Benefits
Telomere elongation, extended lifespan signaling, restored circadian and neuroendocrine function, antioxidant activity, and improved sleep quality.
Dosage Reference
- Typical dose5–10 mg/day
- Cycle length10–20 days
- Frequency1–2 cycles/year
- TimingEvening
Semax
A clinically-used neuropeptide that amplifies BDNF and enhances cerebral blood flow for measurable cognitive gains.
Mechanism of Action
Stimulates BDNF and NGF expression in the brain, modulates dopaminergic and serotonergic neurotransmitter systems, and increases cerebral blood flow, producing rapid nootropic effects.
Key Benefits
Enhanced focus, memory, and cognitive processing. Neuroprotective properties. Mood stabilization. Used clinically for stroke recovery and cognitive decline.
Dosage Reference
- Typical dose200–900 mcg
- Frequency1–2x daily
- TimingMorning
- Cycle length2–4 wk on / 1–2 off
Selank
An anxiolytic neuropeptide that reduces stress and anxiety without sedation, dependence, or withdrawal.
Mechanism of Action
Modulates GABAergic signaling, upregulates BDNF, and regulates endogenous enkephalins, producing anxiolytic effects through a mechanism distinct from benzodiazepines.
Key Benefits
Significant reduction in anxiety and stress response. Mild cognitive enhancement. Mood improvement and immune modulation. No sedation, addiction, or withdrawal risk.
Dosage Reference
- Typical dose250–500 mcg
- Frequency1–3x daily
- TimingAs needed / AM
- Cycle length2–4 weeks
PT-141
A centrally-acting compound that activates sexual arousal pathways directly in the brain.
Mechanism of Action
Activates MC3R and MC4R receptors in the hypothalamus, engaging the brain's sexual arousal circuitry independently of the vascular system, making it effective where other approaches fall short.
Key Benefits
Increased sexual desire and arousal in both men and women. Improved erectile function. Enhanced sensitivity and response. Works for those who do not respond to PDE5 inhibitors.
Dosage Reference
- Injectable dose0.5–2 mg
- Nasal dose1.75 mg / actuation
- Onset1–4 hours prior
- FrequencyMax 1x / 72 hrs
Kisspeptin
Works upstream of the entire hormonal cascade, restoring the body's own testosterone and reproductive signaling.
Mechanism of Action
Activates GPR54 receptors in the hypothalamus to trigger GnRH release, which stimulates LH and FSH production, driving natural testosterone and estrogen synthesis through the intact HPG axis.
Key Benefits
Restoration of endogenous testosterone production, improved fertility markers, preserved HPG axis function, and potential libido enhancement, without bypassing the body's own hormonal system.
Dosage Reference
- Typical dose50–100 mcg
- ProtocolDaily injection
- Cycle length4–12 weeks
- RouteSubcutaneous
For research purposes only. Dosage information is not medical advice. Consult a licensed healthcare provider before use.